Ex vivo manipulation of T cells following exposure to immunomodulatory cytokines or selective depletion of regulatory cells (e.g. CD4, CD25+ T cells) may facilitate the isolation and expansion of tumor-reactive T cells for adoptive therapy. This evidence concerns the gene CD4 and neoplasm.